Misty Dawn Shields, Assistant Professor at Indiana University School of Medicine, shared a post on X:
“A rapidly evolving landscape for KRAS G12C and non-G12C, HER2, MET ex14skipping, and BRAF altered NSCLC. Great discussion among the experts at Texas Lung 25 capturing the nuances of this important topic.”
